Companies: 10,795·Total market cap: $144.5T
Invitae Corporation

Invitae Corporation

NVTANYSEHealthcare
$0.02
$-0.01(-35.59%)
Market Cap$5443367
P/E Ratio
52W High$2.34
52W Low$0.015
SEC Filings

Invitae Corporation (NVTA) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001501134 · NVTA · NYSE · as of Jun 10, 2026

Filing snapshot

812
Total Filings
SCHEDULE 13G/A
Latest Form
2025-01-10
Most Recent
2015
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001501134 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-02-28
Fiscal Year End
Feb 28, 2023
Accession No.
0001501134-23-000024
Primary Document
nvta-20221231.htm
Source: data.sec.gov · CIK 0001501134 · Accession 0001501134-23-000024

Latest Key Filings

10-QQuarterly Report
10-Q
2023-11-08
8-KCurrent Report
8-K
2024-08-08Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-01-10
View
8-KCurrent Report
8-K
2024-08-08
View
8-KCurrent Report
8-K
2024-07-31
View
8-KCurrent Report
8-K
2024-07-01
View
8-KCurrent Report
8-K
2024-06-04
View
8-KCurrent Report
8-K
2024-05-02
View
8-KCurrent Report
8-K
2024-04-04
View
8-KCurrent Report
8-K
2024-03-06
View
25-NSE25-NSE
25-NSE
2024-02-21
View
8-KCurrent Report
8-K
2024-02-14
View
SC 13G/ABeneficial Ownership Report (Amended)
SCHEDULE 13G/A
2024-02-13
View
SC 13G/ABeneficial Ownership Report (Amended)
SC 13G/A
2024-02-13
View
8-KCurrent Report
8-K
2024-02-06
View
SC 13G/ABeneficial Ownership Report (Amended)
AMENDMENT NO. 4
2024-02-05
View
SC 13G/ABeneficial Ownership Report (Amended)
SC 13G/A
2024-01-29
View
Showing 1–15 of 479 filingsForm 4 / 144 hidden· 812 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001501134  |  Exchange: NYSE · Healthcare

Invitae Corporation (NYSE: NVTA) has submitted 812 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001501134, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Invitae Corporation's most comprehensive regulatory disclosure. The most recent Invitae Corporation 10-K was filed on 2023-02-28 for fiscal year ending 2023. Historical NVTA 10-K annual reports are available from 2010 through 2023.

Investors researching Invitae Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10

Frequently Asked Questions

NVTA SEC Filings · 8 questions

Invitae Corporation (NVTA) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 812 filings and access original documents at no cost. Invitae Corporation's CIK is 0001501134.

NVTA SEC filingsInvitae Corporation SEC documentsfind NVTA 10-K